Aim: To compare the efficacy of polymer-free drug-eluting stents (PF-DES) versus other stents in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions. Materials & methods: A systematic review and meta-analysis were performed to identify pertinent randomized controlled trials. The primary end point was the occurrence of target lesion failure. Results: Eight randomized controlled trials were included for a total of 4854 subjects. The PF-DES group experienced a trend in favor of a lower rate of target lesion failure (Incidence rate ratio = 0.91; p = 0.11) and a significantly lower rate of cardiac mortality, as compared with the control group (Incidence rate ratio = 0.82; p = 0.04). However, statistical significance was lost if bare-metal stent patients were excluded and a trend in favor of the PF-DES strategy was reported only for cardiac mortality. Conclusion: PF-DES could be a valuable strategy in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions.
Polymer-free stents for percutaneous coronary intervention in diabetic patients: a systematic review and meta-analysis / Gurgoglione, F. L.; Donelli, D.; Antonelli, M.; Vignali, L.; Benatti, G.; Solinas, E.; Tadonio, I.; Magnani, G.; Denegri, A.; Lazzeroni, D.; Montone, R. A.; Bonadonna, R. C.; Nicolini, F.; Ardissino, D.; Niccoli, G.. - In: FUTURE CARDIOLOGY. - ISSN 1479-6678. - 20:9(2024), pp. 485-497. [10.1080/14796678.2024.2370688]
Polymer-free stents for percutaneous coronary intervention in diabetic patients: a systematic review and meta-analysis
Gurgoglione F. L.;Benatti G.;Tadonio I.;Lazzeroni D.;Bonadonna R. C.;Nicolini F.;Ardissino D.;Niccoli G.
2024-01-01
Abstract
Aim: To compare the efficacy of polymer-free drug-eluting stents (PF-DES) versus other stents in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions. Materials & methods: A systematic review and meta-analysis were performed to identify pertinent randomized controlled trials. The primary end point was the occurrence of target lesion failure. Results: Eight randomized controlled trials were included for a total of 4854 subjects. The PF-DES group experienced a trend in favor of a lower rate of target lesion failure (Incidence rate ratio = 0.91; p = 0.11) and a significantly lower rate of cardiac mortality, as compared with the control group (Incidence rate ratio = 0.82; p = 0.04). However, statistical significance was lost if bare-metal stent patients were excluded and a trend in favor of the PF-DES strategy was reported only for cardiac mortality. Conclusion: PF-DES could be a valuable strategy in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


